by Jordana Choucair | Feb 3, 2022 | Opioid/Substance Use Disorders
A study published in the Lancet found that the opioid epidemic could claim another 1.2 million lives in North America over the next seven years. The researchers warned that the epidemic may widen globally without stricter regulation to stop companies from exporting...
by Jordana Choucair | Feb 3, 2022 | Mental Health
Eleven groups wrote a letter to HHS voicing concerns with the price transparency provision of the law to ban surprise billing. The provision requires most licensed medical practitioners to give patients detailed upfront cost estimates, including a diagnosis, and...
by Jordana Choucair | Feb 3, 2022 | M&A
Amedisys announced it signed a definitive agreement to buy Evolution Health from Envision Healthcare. The deal, which should close by June of this year, will give Amedisys access to the more than 3,300 home health patients Evolution Health serves daily. “Amedisys will...
by Jordana Choucair | Feb 3, 2022 | Life Sciences
Merck & Co. said it expects its sales to surge by up to 18 percent in 2022 compared with last year, primarily driven by demand for the COVID-19 antiviral pill molnupiravir. Merck said sales of the drug, which it developed with Ridgeback Biotherapeutics LP, reached...
by Jordana Choucair | Feb 3, 2022 | Health IT
The HHS Assistant Secretary for Planning and Evaluation (ASPE) released an issue brief indicating income disparities in video versus audio telehealth services. Among telehealth users, the highest share of visits that utilized video services occurred among young adults...
Recent Comments